A nonhemolytic strain of Staphylococcus aureus was transformed with deoxyribonucleic acid extracted from two hemolytic strains of S. aureus. In each case the hemolysin pattern after transformation was identical to that of the donor strain. However, bacteriophage type, serotypes, and other biological properties of the recipient strain remained unaffected.
cipient strain remained unaffected.
Information on transformation in staphylococci has been limited to the studies of Pakula (8) and Dobrzanski (3) who investigated intergeneric activities between streptococci and staphylococci.
It was suggested by other workers (4, 15 ) that genetic transformation does not occur either intra-or interspecifically in staphylococci. The basic obstacle in effecting transformation appears to be the obtaining of high-molecular-weight, biologically active deoxyribonucleic acid (DNA) which would be resistant to the action of staphylococcal deoxyribonuclease, thus permitting the DNA to effect transformation. Riggs and Rosenblum (11) reported that two strains of Staphylococcus aureus were transfected with DNA obtained from staphylococcal phages in hypertonic media.
The investigations mentioned above led us to study transformation in S. aureus; it appears from this study that transformation is achieved by, and may be recognized by, the acquired ability to synthesize beta or delta hemolysins, or both (9).
S. aureus strains 48, 406-10, and 8094 were obtained from human lesions. The patterns of bacteriophage typing (1), the serotypes (7, 10) , and the enzymatic properties of these strains are recorded in Table 1 . Strain 8094 was used as the recipient, and before transformation it could not be induced to produce any hemolysins (14) . Sev DNA was prepared by using a modification of the methods described by Marmur (5, 6) and Saito and Miura (12) . The washed cells were suspended in 0.1 M triethanolamine-glycine buffer (pH 9.0) containing 1% sodium lauryl sulfate and 0.1 M NaCl. The cells were lysed by repeated freezing in an acetone-dry ice mixture and rapid thawing in a water bath at 60 C. Ribonuclease I (Worthington Biochemical Corp., lot 2-4632) and ribonuclease T1 (Sankyo Co., Tokyo, Japan; lot 8M-020) were employed to remove residual ribonucleic acid (RNA) from the product (50 gg of ribonuclease 1, 30 1ug of ribonuclease T1, and 500 ,ug of DNA per ml). After The reaction medium was a hypertonic TSB (BBL; lot 809649) containing 5% NaCl, 0.01 M EDTA, 0.02 units of penicillin per ml, and 0.7 ,g of streptomycin per ml. The concentrations of penicillin and streptomycin used were obtained from calculation of the sublethal doses against the recipient cells used. The cells were harvested from the reaction medium at various times during the growth cycle and exposed to the transforming DNA (final concentration, 15 ALg/ml) for 30 min at 37 C with constant shaking. Although the cells grew quite well in the TSB mixture noted above, no growth, as reflected by change in the number of colony-forming units, was detected in the mixture containing the transforming DNA.
At the end of the incubation period, deoxyribonuclease (final concentration, 25 tsg/ml; 1.5 x 104 units/g; Sigma Chemical Co., St. Louis, Mo.; lot 16b-1760) prepared in a phosphate buffer (pH 7.2) and containing 0.03 M MgCl2 was added. The amount of deoxyribonuclease added was in excess; it was previously titrated to a specific amount of substrate DNA which was fivefold that used in the experiment. Thirty minutes after the addition of the deoxyribonuclease, the cells were inoculated onto 5% (v/v) sheep blood-agar plates and incubated aerobically at 37 C for 48 hr. The number of colony-forming units producing hemolysins was determined using a Quebec colony counter, Table 2 . As a control experiment, DNA pre-treated with deoxyribonuclease and heat-treated DNA (80 C for I hr) were used in the same system to attempt transformation; however, no hemolysin-producing colonies were obtained with these two altered DNA preparations. The same numbers of colonies were observed in the control portion as were observed in the experimental portion of this experiment.
In those colonies which now produce hemolysins there were no changes from the original phage type or serotypes, nor were there any changes in the enzymatic properties previously recorded for the recipient strains. The presence of competent cells was limited to the beginning of the exponential growth phase.
From our results, we believe that we succeeded in effecting transformation of the recipient strain and that the acquired marker of hemolysin production, identical to that of the donor strain, is a valid biological marker. It is also of special interest that neither the phage, serotypes, nor any of the other measured enzymatic properties changed. These results should prove of interest in studies on genetics and hemolysin biosynthesis in the staphylococci. 
